nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—type 2 diabetes mellitus	0.234	0.732	CbGaD
Lapatinib—CYP3A4—type 2 diabetes mellitus	0.0853	0.268	CbGaD
Lapatinib—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0269	0.0668	CbGbCtD
Lapatinib—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0215	0.0534	CbGbCtD
Lapatinib—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0204	0.0507	CbGbCtD
Lapatinib—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0194	0.0483	CbGbCtD
Lapatinib—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0192	0.0476	CbGbCtD
Lapatinib—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0182	0.0452	CbGbCtD
Lapatinib—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0179	0.0446	CbGbCtD
Lapatinib—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0173	0.043	CbGbCtD
Lapatinib—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0163	0.0405	CbGbCtD
Lapatinib—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0163	0.0405	CbGbCtD
Lapatinib—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0153	0.0381	CbGbCtD
Lapatinib—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.015	0.0374	CbGbCtD
Lapatinib—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0145	0.0361	CbGbCtD
Lapatinib—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0141	0.0351	CbGbCtD
Lapatinib—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0132	0.0327	CbGbCtD
Lapatinib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0122	0.0304	CbGbCtD
Lapatinib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0109	0.0271	CbGbCtD
Lapatinib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00997	0.0248	CbGbCtD
Lapatinib—CYP3A5—Losartan—type 2 diabetes mellitus	0.00946	0.0235	CbGbCtD
Lapatinib—CYP2C8—Losartan—type 2 diabetes mellitus	0.0091	0.0226	CbGbCtD
Lapatinib—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00904	0.0225	CbGbCtD
Lapatinib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00872	0.0217	CbGbCtD
Lapatinib—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00835	0.0207	CbGbCtD
Lapatinib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00788	0.0196	CbGbCtD
Lapatinib—CYP2C19—Losartan—type 2 diabetes mellitus	0.00763	0.019	CbGbCtD
Lapatinib—ABCB1—Glyburide—type 2 diabetes mellitus	0.00673	0.0167	CbGbCtD
Lapatinib—ABCB1—Losartan—type 2 diabetes mellitus	0.00616	0.0153	CbGbCtD
Lapatinib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00597	0.0148	CbGbCtD
Lapatinib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00573	0.0142	CbGbCtD
Lapatinib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00573	0.0142	CbGbCtD
Lapatinib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00542	0.0135	CbGbCtD
Lapatinib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00403	0.01	CbGbCtD
Lapatinib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00369	0.00917	CbGbCtD
Lapatinib—TAP1—islet of Langerhans—type 2 diabetes mellitus	0.00241	0.0578	CbGeAlD
Lapatinib—TAP1—nephron tubule—type 2 diabetes mellitus	0.00194	0.0465	CbGeAlD
Lapatinib—PIK3C2B—nephron tubule—type 2 diabetes mellitus	0.00182	0.0437	CbGeAlD
Lapatinib—TAP1—pancreas—type 2 diabetes mellitus	0.00169	0.0406	CbGeAlD
Lapatinib—TAP1—cortex of kidney—type 2 diabetes mellitus	0.00166	0.0398	CbGeAlD
Lapatinib—PI4KB—islet of Langerhans—type 2 diabetes mellitus	0.00164	0.0395	CbGeAlD
Lapatinib—PIK3C2B—pancreas—type 2 diabetes mellitus	0.00159	0.0381	CbGeAlD
Lapatinib—PIK3C2B—cortex of kidney—type 2 diabetes mellitus	0.00156	0.0374	CbGeAlD
Lapatinib—TAP1—adipose tissue—type 2 diabetes mellitus	0.00153	0.0369	CbGeAlD
Lapatinib—PIK3C2B—adipose tissue—type 2 diabetes mellitus	0.00144	0.0346	CbGeAlD
Lapatinib—PI4KB—nephron tubule—type 2 diabetes mellitus	0.00132	0.0318	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—type 2 diabetes mellitus	0.00127	0.0305	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—type 2 diabetes mellitus	0.00127	0.0305	CbGeAlD
Lapatinib—ERBB2—kidney—type 2 diabetes mellitus	0.00124	0.0299	CbGeAlD
Lapatinib—ERBB2—pancreas—type 2 diabetes mellitus	0.00123	0.0297	CbGeAlD
Lapatinib—ERBB4—cortex of kidney—type 2 diabetes mellitus	0.00121	0.0291	CbGeAlD
Lapatinib—PI4KB—kidney—type 2 diabetes mellitus	0.00116	0.028	CbGeAlD
Lapatinib—PI4KB—pancreas—type 2 diabetes mellitus	0.00116	0.0278	CbGeAlD
Lapatinib—PI4KB—cortex of kidney—type 2 diabetes mellitus	0.00113	0.0272	CbGeAlD
Lapatinib—ERBB2—adipose tissue—type 2 diabetes mellitus	0.00112	0.0269	CbGeAlD
Lapatinib—ERBB4—adipose tissue—type 2 diabetes mellitus	0.00112	0.0269	CbGeAlD
Lapatinib—PIK3C2B—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00111	0.548	CbGdCrCtD
Lapatinib—TAP1—liver—type 2 diabetes mellitus	0.00108	0.0259	CbGeAlD
Lapatinib—PI4KB—adipose tissue—type 2 diabetes mellitus	0.00105	0.0252	CbGeAlD
Lapatinib—PIK3C2B—liver—type 2 diabetes mellitus	0.00101	0.0243	CbGeAlD
Lapatinib—EGFR—adipose tissue—type 2 diabetes mellitus	0.000949	0.0228	CbGeAlD
Lapatinib—ERBB2—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000917	0.452	CbGdCrCtD
Lapatinib—ERBB2—liver—type 2 diabetes mellitus	0.000785	0.0189	CbGeAlD
Lapatinib—Gefitinib—EGFR—type 2 diabetes mellitus	0.000748	0.594	CrCbGaD
Lapatinib—PI4KB—liver—type 2 diabetes mellitus	0.000736	0.0177	CbGeAlD
Lapatinib—EGFR—liver—type 2 diabetes mellitus	0.000666	0.016	CbGeAlD
Lapatinib—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000431	0.0104	CbGeAlD
Lapatinib—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000347	0.00833	CbGeAlD
Lapatinib—CYP2C8—kidney—type 2 diabetes mellitus	0.000338	0.00812	CbGeAlD
Lapatinib—CYP3A5—kidney—type 2 diabetes mellitus	0.000305	0.00732	CbGeAlD
Lapatinib—CYP3A5—pancreas—type 2 diabetes mellitus	0.000303	0.00728	CbGeAlD
Lapatinib—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000297	0.00713	CbGeAlD
Lapatinib—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000275	0.0066	CbGeAlD
Lapatinib—Gefitinib—CYP3A4—type 2 diabetes mellitus	0.000273	0.217	CrCbGaD
Lapatinib—CYP2C19—liver—type 2 diabetes mellitus	0.000245	0.00588	CbGeAlD
Lapatinib—Gefitinib—ALB—type 2 diabetes mellitus	0.000238	0.189	CrCbGaD
Lapatinib—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000229	0.0055	CbGeAlD
Lapatinib—CYP3A4—kidney—type 2 diabetes mellitus	0.000229	0.0055	CbGeAlD
Lapatinib—CYP2C8—liver—type 2 diabetes mellitus	0.000213	0.00513	CbGeAlD
Lapatinib—ABCB1—retina—type 2 diabetes mellitus	0.000196	0.0047	CbGeAlD
Lapatinib—CYP3A5—liver—type 2 diabetes mellitus	0.000193	0.00463	CbGeAlD
Lapatinib—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000184	0.00443	CbGeAlD
Lapatinib—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000165	0.00398	CbGeAlD
Lapatinib—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00131	CcSEcCtD
Lapatinib—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—Palpitations—Valsartan—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—ABCB1—kidney—type 2 diabetes mellitus	0.000162	0.00389	CbGeAlD
Lapatinib—Infection—Gliclazide—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000162	0.0013	CcSEcCtD
Lapatinib—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000161	0.0013	CcSEcCtD
Lapatinib—ABCB1—pancreas—type 2 diabetes mellitus	0.000161	0.00387	CbGeAlD
Lapatinib—Palpitations—Orlistat—type 2 diabetes mellitus	0.00016	0.00129	CcSEcCtD
Lapatinib—Cough—Valsartan—type 2 diabetes mellitus	0.00016	0.00129	CcSEcCtD
Lapatinib—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00016	0.00129	CcSEcCtD
Lapatinib—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00016	0.00129	CcSEcCtD
Lapatinib—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00016	0.00128	CcSEcCtD
Lapatinib—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00016	0.00128	CcSEcCtD
Lapatinib—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000159	0.00128	CcSEcCtD
Lapatinib—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Lapatinib—Cough—Orlistat—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Lapatinib—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Lapatinib—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Lapatinib—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000158	0.00379	CbGeAlD
Lapatinib—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Lapatinib—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00127	CcSEcCtD
Lapatinib—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00126	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000157	0.00126	CcSEcCtD
Lapatinib—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000156	0.00126	CcSEcCtD
Lapatinib—Myalgia—Valsartan—type 2 diabetes mellitus	0.000156	0.00126	CcSEcCtD
Lapatinib—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000156	0.00125	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000155	0.00125	CcSEcCtD
Lapatinib—Angiopathy—Losartan—type 2 diabetes mellitus	0.000155	0.00124	CcSEcCtD
Lapatinib—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000155	0.00124	CcSEcCtD
Lapatinib—Myalgia—Orlistat—type 2 diabetes mellitus	0.000154	0.00124	CcSEcCtD
Lapatinib—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000154	0.00124	CcSEcCtD
Lapatinib—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000154	0.00123	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000153	0.00123	CcSEcCtD
Lapatinib—Alopecia—Losartan—type 2 diabetes mellitus	0.000151	0.00121	CcSEcCtD
Lapatinib—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000151	0.00121	CcSEcCtD
Lapatinib—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00015	0.00121	CcSEcCtD
Lapatinib—Vomiting—Glipizide—type 2 diabetes mellitus	0.00015	0.00121	CcSEcCtD
Lapatinib—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00015	0.0012	CcSEcCtD
Lapatinib—Infection—Valsartan—type 2 diabetes mellitus	0.000149	0.0012	CcSEcCtD
Lapatinib—Rash—Glipizide—type 2 diabetes mellitus	0.000149	0.0012	CcSEcCtD
Lapatinib—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000149	0.00119	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Lapatinib—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Lapatinib—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Lapatinib—Headache—Glipizide—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Lapatinib—Palpitations—Metformin—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Lapatinib—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000147	0.00119	CcSEcCtD
Lapatinib—Infection—Orlistat—type 2 diabetes mellitus	0.000147	0.00118	CcSEcCtD
Lapatinib—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000147	0.00118	CcSEcCtD
Lapatinib—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000146	0.00351	CbGeAlD
Lapatinib—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000146	0.00117	CcSEcCtD
Lapatinib—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000145	0.00117	CcSEcCtD
Lapatinib—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000145	0.00117	CcSEcCtD
Lapatinib—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000145	0.00117	CcSEcCtD
Lapatinib—CYP3A4—liver—type 2 diabetes mellitus	0.000145	0.00347	CbGeAlD
Lapatinib—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000144	0.00116	CcSEcCtD
Lapatinib—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000144	0.00116	CcSEcCtD
Lapatinib—Back pain—Losartan—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Lapatinib—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Lapatinib—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Lapatinib—Anorexia—Valsartan—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Lapatinib—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000142	0.00115	CcSEcCtD
Lapatinib—Myalgia—Metformin—type 2 diabetes mellitus	0.000142	0.00114	CcSEcCtD
Lapatinib—Headache—Pioglitazone—type 2 diabetes mellitus	0.000142	0.00114	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Lapatinib—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000141	0.00113	CcSEcCtD
Lapatinib—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00014	0.00113	CcSEcCtD
Lapatinib—Nausea—Glipizide—type 2 diabetes mellitus	0.00014	0.00113	CcSEcCtD
Lapatinib—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00014	0.00113	CcSEcCtD
Lapatinib—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00112	CcSEcCtD
Lapatinib—Constipation—Gliclazide—type 2 diabetes mellitus	0.000139	0.00112	CcSEcCtD
Lapatinib—Rash—Glimepiride—type 2 diabetes mellitus	0.000139	0.00112	CcSEcCtD
Lapatinib—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000139	0.00111	CcSEcCtD
Lapatinib—Rash—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00111	CcSEcCtD
Lapatinib—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00111	CcSEcCtD
Lapatinib—Headache—Glimepiride—type 2 diabetes mellitus	0.000138	0.00111	CcSEcCtD
Lapatinib—Cough—Irbesartan—type 2 diabetes mellitus	0.000138	0.00111	CcSEcCtD
Lapatinib—Headache—Sitagliptin—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Lapatinib—Anaemia—Losartan—type 2 diabetes mellitus	0.000137	0.0011	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000136	0.0011	CcSEcCtD
Lapatinib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000136	0.00109	CcSEcCtD
Lapatinib—Infection—Metformin—type 2 diabetes mellitus	0.000135	0.00109	CcSEcCtD
Lapatinib—Insomnia—Valsartan—type 2 diabetes mellitus	0.000135	0.00109	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000135	0.00108	CcSEcCtD
Lapatinib—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Lapatinib—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Lapatinib—Insomnia—Orlistat—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Lapatinib—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Lapatinib—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Lapatinib—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Lapatinib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Lapatinib—Leukopenia—Losartan—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Lapatinib—Skin disorder—Metformin—type 2 diabetes mellitus	0.000132	0.00107	CcSEcCtD
Lapatinib—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.00106	CcSEcCtD
Lapatinib—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000132	0.00106	CcSEcCtD
Lapatinib—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.00106	CcSEcCtD
Lapatinib—Palpitations—Losartan—type 2 diabetes mellitus	0.000131	0.00105	CcSEcCtD
Lapatinib—Nausea—Glimepiride—type 2 diabetes mellitus	0.000131	0.00105	CcSEcCtD
Lapatinib—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Lapatinib—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Lapatinib—Asthenia—Glyburide—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Lapatinib—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Lapatinib—Anorexia—Metformin—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Lapatinib—Cough—Losartan—type 2 diabetes mellitus	0.000129	0.00104	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000129	0.00104	CcSEcCtD
Lapatinib—Alopecia—Ramipril—type 2 diabetes mellitus	0.000129	0.00104	CcSEcCtD
Lapatinib—Fatigue—Valsartan—type 2 diabetes mellitus	0.000129	0.00104	CcSEcCtD
Lapatinib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000129	0.00104	CcSEcCtD
Lapatinib—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000129	0.00103	CcSEcCtD
Lapatinib—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000129	0.00103	CcSEcCtD
Lapatinib—Pruritus—Glyburide—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Constipation—Valsartan—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Infection—Irbesartan—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Fatigue—Orlistat—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Lapatinib—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000127	0.00102	CcSEcCtD
Lapatinib—Arthralgia—Losartan—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Lapatinib—Myalgia—Losartan—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Lapatinib—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Lapatinib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000126	0.00101	CcSEcCtD
Lapatinib—Rash—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Lapatinib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Lapatinib—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Lapatinib—Headache—Bromocriptine—type 2 diabetes mellitus	0.000124	0.001	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000124	0.000999	CcSEcCtD
Lapatinib—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000124	0.000999	CcSEcCtD
Lapatinib—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000986	CcSEcCtD
Lapatinib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000122	0.000985	CcSEcCtD
Lapatinib—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000122	0.000978	CcSEcCtD
Lapatinib—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000121	0.000974	CcSEcCtD
Lapatinib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000121	0.000973	CcSEcCtD
Lapatinib—Infection—Losartan—type 2 diabetes mellitus	0.00012	0.000968	CcSEcCtD
Lapatinib—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00012	0.000966	CcSEcCtD
Lapatinib—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00012	0.000965	CcSEcCtD
Lapatinib—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000119	0.000955	CcSEcCtD
Lapatinib—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000119	0.000953	CcSEcCtD
Lapatinib—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.000952	CcSEcCtD
Lapatinib—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000948	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000118	0.000947	CcSEcCtD
Lapatinib—Fatigue—Metformin—type 2 diabetes mellitus	0.000118	0.000945	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000117	0.000943	CcSEcCtD
Lapatinib—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000941	CcSEcCtD
Lapatinib—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000117	0.00094	CcSEcCtD
Lapatinib—Constipation—Metformin—type 2 diabetes mellitus	0.000117	0.000938	CcSEcCtD
Lapatinib—Anorexia—Losartan—type 2 diabetes mellitus	0.000115	0.000928	CcSEcCtD
Lapatinib—Vomiting—Glyburide—type 2 diabetes mellitus	0.000115	0.000928	CcSEcCtD
Lapatinib—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000115	0.000927	CcSEcCtD
Lapatinib—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000923	CcSEcCtD
Lapatinib—Rash—Glyburide—type 2 diabetes mellitus	0.000114	0.00092	CcSEcCtD
Lapatinib—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000114	0.000919	CcSEcCtD
Lapatinib—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000114	0.000916	CcSEcCtD
Lapatinib—Headache—Glyburide—type 2 diabetes mellitus	0.000114	0.000914	CcSEcCtD
Lapatinib—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000911	CcSEcCtD
Lapatinib—Palpitations—Ramipril—type 2 diabetes mellitus	0.000112	0.000904	CcSEcCtD
Lapatinib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000112	0.0009	CcSEcCtD
Lapatinib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000111	0.000897	CcSEcCtD
Lapatinib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000111	0.000897	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.000893	CcSEcCtD
Lapatinib—Cough—Ramipril—type 2 diabetes mellitus	0.000111	0.000893	CcSEcCtD
Lapatinib—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000111	0.000892	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00011	0.000887	CcSEcCtD
Lapatinib—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00011	0.000887	CcSEcCtD
Lapatinib—Constipation—Irbesartan—type 2 diabetes mellitus	0.00011	0.000885	CcSEcCtD
Lapatinib—Insomnia—Losartan—type 2 diabetes mellitus	0.00011	0.000881	CcSEcCtD
Lapatinib—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000109	0.000877	CcSEcCtD
Lapatinib—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000108	0.000871	CcSEcCtD
Lapatinib—Myalgia—Ramipril—type 2 diabetes mellitus	0.000108	0.000871	CcSEcCtD
Lapatinib—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000108	0.000868	CcSEcCtD
Lapatinib—Nausea—Glyburide—type 2 diabetes mellitus	0.000108	0.000867	CcSEcCtD
Lapatinib—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000108	0.000867	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000108	0.000865	CcSEcCtD
Lapatinib—Asthenia—Valsartan—type 2 diabetes mellitus	0.000107	0.000864	CcSEcCtD
Lapatinib—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000107	0.000857	CcSEcCtD
Lapatinib—Asthenia—Orlistat—type 2 diabetes mellitus	0.000106	0.000854	CcSEcCtD
Lapatinib—Pruritus—Valsartan—type 2 diabetes mellitus	0.000106	0.000852	CcSEcCtD
Lapatinib—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000105	0.000847	CcSEcCtD
Lapatinib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000105	0.000846	CcSEcCtD
Lapatinib—Pruritus—Orlistat—type 2 diabetes mellitus	0.000105	0.000842	CcSEcCtD
Lapatinib—Fatigue—Losartan—type 2 diabetes mellitus	0.000104	0.00084	CcSEcCtD
Lapatinib—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000104	0.000835	CcSEcCtD
Lapatinib—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000104	0.000833	CcSEcCtD
Lapatinib—Constipation—Losartan—type 2 diabetes mellitus	0.000104	0.000833	CcSEcCtD
Lapatinib—Rash—Gliclazide—type 2 diabetes mellitus	0.000103	0.000826	CcSEcCtD
Lapatinib—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000103	0.000826	CcSEcCtD
Lapatinib—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000824	CcSEcCtD
Lapatinib—ABCB1—liver—type 2 diabetes mellitus	0.000102	0.00246	CbGeAlD
Lapatinib—Headache—Gliclazide—type 2 diabetes mellitus	0.000102	0.000821	CcSEcCtD
Lapatinib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.000819	CcSEcCtD
Lapatinib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.000818	CcSEcCtD
Lapatinib—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000101	0.000814	CcSEcCtD
Lapatinib—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000101	0.000811	CcSEcCtD
Lapatinib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.9e-05	0.000796	CcSEcCtD
Lapatinib—Anorexia—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000796	CcSEcCtD
Lapatinib—Asthenia—Metformin—type 2 diabetes mellitus	9.78e-05	0.000787	CcSEcCtD
Lapatinib—Nausea—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000779	CcSEcCtD
Lapatinib—Pruritus—Metformin—type 2 diabetes mellitus	9.64e-05	0.000776	CcSEcCtD
Lapatinib—Abdominal pain—Losartan—type 2 diabetes mellitus	9.57e-05	0.00077	CcSEcCtD
Lapatinib—Vomiting—Valsartan—type 2 diabetes mellitus	9.52e-05	0.000766	CcSEcCtD
Lapatinib—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000762	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000761	CcSEcCtD
Lapatinib—Rash—Valsartan—type 2 diabetes mellitus	9.44e-05	0.000759	CcSEcCtD
Lapatinib—Dermatitis—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000759	CcSEcCtD
Lapatinib—Vomiting—Orlistat—type 2 diabetes mellitus	9.41e-05	0.000757	CcSEcCtD
Lapatinib—Insomnia—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000755	CcSEcCtD
Lapatinib—Headache—Valsartan—type 2 diabetes mellitus	9.38e-05	0.000754	CcSEcCtD
Lapatinib—Diarrhoea—Metformin—type 2 diabetes mellitus	9.33e-05	0.00075	CcSEcCtD
Lapatinib—Rash—Orlistat—type 2 diabetes mellitus	9.33e-05	0.00075	CcSEcCtD
Lapatinib—Dermatitis—Orlistat—type 2 diabetes mellitus	9.32e-05	0.00075	CcSEcCtD
Lapatinib—Headache—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000745	CcSEcCtD
Lapatinib—Dyspnoea—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000745	CcSEcCtD
Lapatinib—Asthenia—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000742	CcSEcCtD
Lapatinib—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000735	CcSEcCtD
Lapatinib—Pruritus—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000732	CcSEcCtD
Lapatinib—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000726	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000721	CcSEcCtD
Lapatinib—Fatigue—Ramipril—type 2 diabetes mellitus	8.95e-05	0.00072	CcSEcCtD
Lapatinib—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.92e-05	0.000718	CcSEcCtD
Lapatinib—Nausea—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000715	CcSEcCtD
Lapatinib—Constipation—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000714	CcSEcCtD
Lapatinib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.8e-05	0.000708	CcSEcCtD
Lapatinib—Nausea—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000707	CcSEcCtD
Lapatinib—Asthenia—Losartan—type 2 diabetes mellitus	8.69e-05	0.000699	CcSEcCtD
Lapatinib—Vomiting—Metformin—type 2 diabetes mellitus	8.67e-05	0.000697	CcSEcCtD
Lapatinib—Rash—Metformin—type 2 diabetes mellitus	8.6e-05	0.000691	CcSEcCtD
Lapatinib—Dermatitis—Metformin—type 2 diabetes mellitus	8.59e-05	0.000691	CcSEcCtD
Lapatinib—Pruritus—Losartan—type 2 diabetes mellitus	8.57e-05	0.000689	CcSEcCtD
Lapatinib—Headache—Metformin—type 2 diabetes mellitus	8.54e-05	0.000687	CcSEcCtD
Lapatinib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000683	CcSEcCtD
Lapatinib—Diarrhoea—Losartan—type 2 diabetes mellitus	8.28e-05	0.000666	CcSEcCtD
Lapatinib—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.21e-05	0.00066	CcSEcCtD
Lapatinib—Vomiting—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000658	CcSEcCtD
Lapatinib—Rash—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000652	CcSEcCtD
Lapatinib—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000652	CcSEcCtD
Lapatinib—Nausea—Metformin—type 2 diabetes mellitus	8.1e-05	0.000651	CcSEcCtD
Lapatinib—Headache—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000648	CcSEcCtD
Lapatinib—Vomiting—Losartan—type 2 diabetes mellitus	7.7e-05	0.000619	CcSEcCtD
Lapatinib—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000615	CcSEcCtD
Lapatinib—Nausea—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000615	CcSEcCtD
Lapatinib—Rash—Losartan—type 2 diabetes mellitus	7.63e-05	0.000614	CcSEcCtD
Lapatinib—Dermatitis—Losartan—type 2 diabetes mellitus	7.63e-05	0.000613	CcSEcCtD
Lapatinib—Headache—Losartan—type 2 diabetes mellitus	7.58e-05	0.00061	CcSEcCtD
Lapatinib—Asthenia—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000599	CcSEcCtD
Lapatinib—Pruritus—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000591	CcSEcCtD
Lapatinib—Nausea—Losartan—type 2 diabetes mellitus	7.19e-05	0.000578	CcSEcCtD
Lapatinib—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000571	CcSEcCtD
Lapatinib—Vomiting—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000531	CcSEcCtD
Lapatinib—Rash—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000527	CcSEcCtD
Lapatinib—Dermatitis—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000526	CcSEcCtD
Lapatinib—Headache—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000523	CcSEcCtD
Lapatinib—Nausea—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000496	CcSEcCtD
Lapatinib—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.52e-06	3.22e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.52e-06	3.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	3.51e-06	3.21e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—type 2 diabetes mellitus	3.48e-06	3.19e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—type 2 diabetes mellitus	3.48e-06	3.18e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.47e-06	3.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.47e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	3.47e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	3.47e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.46e-06	3.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RELA—type 2 diabetes mellitus	3.44e-06	3.15e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.43e-06	3.14e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—type 2 diabetes mellitus	3.43e-06	3.14e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—type 2 diabetes mellitus	3.43e-06	3.14e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	3.42e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	3.42e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	3.42e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.4e-06	3.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.4e-06	3.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.4e-06	3.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C3—type 2 diabetes mellitus	3.39e-06	3.1e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	3.38e-06	3.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PIK3R1—type 2 diabetes mellitus	3.38e-06	3.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—type 2 diabetes mellitus	3.38e-06	3.09e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.37e-06	3.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	3.36e-06	3.08e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	3.34e-06	3.06e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	3.34e-06	3.06e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	3.34e-06	3.06e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	3.33e-06	3.05e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	3.33e-06	3.04e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.33e-06	3.04e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.31e-06	3.03e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	3.31e-06	3.03e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	3.29e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.29e-06	3.01e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	3.28e-06	3e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—type 2 diabetes mellitus	3.27e-06	2.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.26e-06	2.98e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	3.25e-06	2.98e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	3.25e-06	2.98e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.24e-06	2.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.23e-06	2.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.23e-06	2.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	3.22e-06	2.95e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—type 2 diabetes mellitus	3.21e-06	2.94e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.2e-06	2.92e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.19e-06	2.92e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.19e-06	2.92e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.18e-06	2.91e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.17e-06	2.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.17e-06	2.9e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—type 2 diabetes mellitus	3.16e-06	2.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	3.16e-06	2.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	3.16e-06	2.89e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	3.16e-06	2.89e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.13e-06	2.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—type 2 diabetes mellitus	3.13e-06	2.86e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.13e-06	2.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.12e-06	2.86e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.1e-06	2.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.1e-06	2.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—type 2 diabetes mellitus	3.09e-06	2.83e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	3.07e-06	2.81e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.06e-06	2.8e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.02e-06	2.77e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.02e-06	2.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.02e-06	2.76e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	3.01e-06	2.76e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3e-06	2.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.99e-06	2.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.98e-06	2.73e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	2.97e-06	2.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	2.97e-06	2.72e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	2.95e-06	2.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.95e-06	2.7e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	2.94e-06	2.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NFKB1—type 2 diabetes mellitus	2.9e-06	2.66e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.9e-06	2.65e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.9e-06	2.65e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.89e-06	2.64e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.89e-06	2.64e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.89e-06	2.64e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.89e-06	2.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—type 2 diabetes mellitus	2.89e-06	2.64e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.87e-06	2.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.87e-06	2.62e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	2.86e-06	2.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.85e-06	2.61e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.83e-06	2.59e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.82e-06	2.58e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.82e-06	2.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—type 2 diabetes mellitus	2.77e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.77e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.73e-06	2.5e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.71e-06	2.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SRC—type 2 diabetes mellitus	2.71e-06	2.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INS—type 2 diabetes mellitus	2.7e-06	2.47e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.66e-06	2.44e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.66e-06	2.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.65e-06	2.43e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.61e-06	2.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.61e-06	2.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.61e-06	2.39e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.58e-06	2.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.58e-06	2.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.56e-06	2.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.56e-06	2.34e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.56e-06	2.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.55e-06	2.33e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.55e-06	2.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.53e-06	2.32e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.53e-06	2.31e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.51e-06	2.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—SRC—type 2 diabetes mellitus	2.5e-06	2.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.5e-06	2.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.5e-06	2.29e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.5e-06	2.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.49e-06	2.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.48e-06	2.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.48e-06	2.27e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.45e-06	2.25e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.45e-06	2.24e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.44e-06	2.23e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.44e-06	2.23e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.4e-06	2.2e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—type 2 diabetes mellitus	2.4e-06	2.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.38e-06	2.18e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.37e-06	2.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.37e-06	2.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.37e-06	2.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.36e-06	2.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.36e-06	2.16e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.35e-06	2.15e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.33e-06	2.13e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.32e-06	2.12e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.31e-06	2.11e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.31e-06	2.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.3e-06	2.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.3e-06	2.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.3e-06	2.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.28e-06	2.09e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.28e-06	2.09e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.27e-06	2.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.27e-06	2.08e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.25e-06	2.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.24e-06	2.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—type 2 diabetes mellitus	2.23e-06	2.04e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.23e-06	2.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.23e-06	2.04e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.23e-06	2.04e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.22e-06	2.03e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.22e-06	2.03e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.21e-06	2.03e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.21e-06	2.03e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.2e-06	2.01e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.2e-06	2.01e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.19e-06	2e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.19e-06	2e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.16e-06	1.98e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.16e-06	1.98e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.16e-06	1.97e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.13e-06	1.95e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.1e-06	1.92e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.06e-06	1.88e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.06e-06	1.88e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.06e-06	1.88e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.06e-06	1.88e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.05e-06	1.87e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.02e-06	1.85e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.01e-06	1.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.01e-06	1.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	2e-06	1.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.99e-06	1.82e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	1.81e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.96e-06	1.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.96e-06	1.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.95e-06	1.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.95e-06	1.78e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.93e-06	1.77e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.91e-06	1.75e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.91e-06	1.74e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.91e-06	1.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.9e-06	1.74e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.89e-06	1.73e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.89e-06	1.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.88e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.88e-06	1.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.88e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.87e-06	1.71e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.86e-06	1.7e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.86e-06	1.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.84e-06	1.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—type 2 diabetes mellitus	1.82e-06	1.67e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.79e-06	1.63e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.79e-06	1.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	1.75e-06	1.6e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.73e-06	1.58e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	1.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.7e-06	1.56e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.7e-06	1.56e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—type 2 diabetes mellitus	1.68e-06	1.54e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—type 2 diabetes mellitus	1.68e-06	1.54e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.67e-06	1.53e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.66e-06	1.52e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.64e-06	1.5e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.64e-06	1.5e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.63e-06	1.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.56e-06	1.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—type 2 diabetes mellitus	1.55e-06	1.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.54e-06	1.41e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.54e-06	1.41e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.53e-06	1.4e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.53e-06	1.4e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.51e-06	1.38e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	1.37e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.49e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.47e-06	1.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-06	1.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-06	1.34e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.43e-06	1.31e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.43e-06	1.31e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.43e-06	1.31e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.4e-06	1.28e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.37e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.37e-06	1.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-06	1.22e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.33e-06	1.22e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.31e-06	1.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	1.2e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.26e-06	1.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.24e-06	1.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.2e-06	1.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.18e-06	1.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.18e-06	1.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.17e-06	1.07e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.16e-06	1.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	9.95e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.02e-06	9.36e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1e-06	9.18e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.2e-07	8.42e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.8e-07	8.05e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.8e-07	8.05e-06	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	8.7e-07	7.96e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.05e-07	7.36e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	7.53e-07	6.9e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.73e-07	6.15e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.56e-07	6.01e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.04e-07	3.7e-06	CbGpPWpGaD
